Navigation Links
Rheumatoid Arthritis a Threat to the Heart
Date:10/27/2008

Greater risk of heart attack, and more complications later, studies find

MONDAY, Oct. 27 (HealthDay News) -- People newly diagnosed with rheumatoid arthritis face twice the risk of a heart attack, and those who do suffer a heart attack tend to have more heart-related complications, new research says.

It seems that a condition called diastolic dysfunction, which causes the lower chambers of the heart to become stiff, is the culprit. Diastolic dysfunction impairs the ability of the ventricles to fill with blood and can lead to heart failure, the researchers said.

These are the conclusions of three reports presented at the American College of Rheumatology (ACR) annual scientific meeting, which runs from Oct. 24-29, in San Francisco.

"Rheumatoid arthritis patients not only have more heart attacks and heart failures, but they also have worse prognosis once they have a cardiovascular event," said Dr. Hilal Maradit Kremers, lead researcher on one of the studies and an epidemiologist at the Mayo Clinic in Rochester, Minn.

For the study, Kremers' team followed 38 patients with rheumatoid arthritis who had suffered a heart attack. Then they compared these patients with patients without rheumatoid arthritis who also had a heart attack.

The researchers found that the rheumatoid arthritis patients had a 45 percent greater risk of developing heart failure after a heart attack, compared with the general population, and a 75 percent greater risk of dying.

Kremers said patients with rheumatoid arthritis should take all the usual precautions to reduce their risk of a heart attack, including proper diet, exercise, no smoking and maintaining a healthy weight. "Try to avoid to get that heart attack," she said.

For the second study, Marie Gunnarsson, a doctoral student at the Institute of Environmental Medicine at the Karolinska Institute in Stockholm, Sweden, and colleagues found that the risk
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Biologic treatment for rheumatoid arthritis and the risk of cancer
2. Genes Boost Risk for Rheumatoid Arthritis, Lupus
3. The genes involved in rheumatoid arthritis identified
4. Genome Area Linked to Rheumatoid Arthritis
5. Meditation therapy for rheumatoid arthritis patients
6. Meditation May Help Rheumatoid Arthritis Sufferers
7. Researchers identify genes that increase rheumatoid arthritis risk
8. The widening mortality gap between people with rheumatoid arthritis and the general population
9. Rheumatoid Arthritis Death Rate Unchanged
10. Drugs Can Ease Juvenile Rheumatoid Arthritis
11. Rheumatoid Arthritis Boosts Heart Disease Threat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... procedures vary widely and are higher than generally thought, raising concerns ... by University of California, San Francisco (UCSF) imaging specialists. ... ... -- Radiation doses from common CT procedures vary widely and are ... according to a new study led by University of California, ...
(Date:12/14/2009)... Critical to Stemming Tide of Tens of Thousands ... WASHINGTON, Dec. 14 Legislation approved by ... will be crucial in helping to reduce tens ... each year in the United States, the ... The provision was included in the FY ...
(Date:12/14/2009)... On December 9, 2009, the United States Court of ... private insurance companies are "plans" and therefore subject to ... courts have held that contracts issued by insurance companies ... Section 1347, US vs. Frost is the ... to be a "plan," because, as the government claimed ...
(Date:12/14/2009)... future cancers could be linked to scans performed in 2007 ... CT scans are exposing patients to far more radiation than ... thousands of cancers a year, two new studies claim. , ... of the Archives of Internal Medicine , the study ... Redberg, are calling on clinicians to limit radiation exposure to ...
(Date:12/14/2009)... of scientists from the UC San Diego School of ... protein switch that helps prevent liver damage, including inflammation, ... understanding of how the protein, TAK1, works could lead ... and cancer. , "TAK1 appears to be a ... MD, professor of medicine and Dean of the UC ...
Breaking Medicine News(10 mins):Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 2Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 3Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 4Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 5Health News:NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange 2Health News:Insurance Now Subject to Federal Jurisdiction 2Health News:Studies Quantify Cancer Risks From CT Scans 2Health News:Studies Quantify Cancer Risks From CT Scans 3Health News:Studies Quantify Cancer Risks From CT Scans 4Health News:Scientists uncover protective mechanism against liver cancer 2
... Researchers at University College London have developed a new ... directly to the human skeleton// . This is done ... called the early clinical trials as promising. ... by using a titanium rod attached directly to the ...
... that the Central Goldfields Shire is getting notorious for poor ... by the Human Services Department that chose to study the ... into the harmful effects of tobacco, alcohol use, lack of ... Melbourne is reported to be in the pink of health ...
... discovered by two scientists Vivian Cheung and Warren Ewens ... that are recessively inherited. ,Gene expression patterns ... this new diagnostic tool was found to depend on ... ,As a model for their work, Cheung ...
... the International Journal of Radiation Oncology, no appreciable risks ... the development of rectal cancer. ,Wayne S. ... at the Ottawa Hospital Regional Cancer Centre in Ontario ... helped people choosing radiation therapy as one of the ...
... consultative committee Sunday said medicines sold in shops would ... Oct 2. ,The decision was taken in a ... ministry of chemicals, fertilizers and steel. The members were ... ,The members decided that the 354 drugs in the ...
... investigating for an alternative menopausal treatment have found that ... ,Gabapentin, a seizure drug lowered hot flashes ... of the cells, which helped in lowering body temperature. ... been investigating new therapies for hot flashes for several ...
Other Medicine News:Health News:New Diagnostic Tool Uncovered Gene Expression Patterns in Recessive Genetic Disorders 2Health News:Research Finds Lesser Rectal Cancer Risks Associated with Prostatic Irradiation 2Health News:Gabapentin Reduced Menopausal Symptoms as Estrogen – Study Find 2
(Date:12/14/2009)... MOUNTAIN VIEW, Calif., Dec. 14 Alexza Pharmaceuticals, ... has submitted its New Drug Application (NDA) for Staccato® ... (FDA). AZ-004 is an inhalation product candidate being ... with schizophrenia or bipolar disorder. The IND for ... in August 2005. ,, "AZ-004 has delivered a predictable ...
(Date:12/14/2009)... Corgenix Medical Corporation (OTC Bulletin ... of diagnostic test kits, and BG Medicine, ... company, announced today a supply agreement whereby ... in enzyme-linked immunosorbent assay (ELISA) microtiter format ... seeking regulatory clearance in the United States ...
(Date:12/14/2009)... Southridge LLC ("Southridge"), an investment firm that provides ... announce that its affiliated fund has closed a private ... equity financing to Imaging Diagnostic Systems, Inc. (OTCBB: IMDS). ... growth of Imaging Diagnostic Systems, Southridge has paved a ... the field of early breast cancer detection," said Stephen ...
Breaking Medicine Technology:Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM) 2Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc. 2Covering Kids 26 Families with Health Insurance is Goal of Back to School Outreach Campaign 54850 1Covering Kids 26 Families with Health Insurance is Goal of Back to School Outreach Campaign 54850 2New Jersey Surgery Centers Pick Health Informatics Consulting to Implement Patient Electronic Health Record Systems 13630 1New Jersey Surgery Centers Pick Health Informatics Consulting to Implement Patient Electronic Health Record Systems 13630 2Los Gatos Research Introduces Second Generation Liquid Water Isotope Analyzer 13628 1Los Gatos Research Introduces Second Generation Liquid Water Isotope Analyzer 13628 2
... Zevalin as consolidation therapy after remission induction in previously untreated patients ... ... July 22 Cell Therapeutics, Inc.,(CTI) (Nasdaq and MTA: CTIC) announced today ... Administration (FDA) in September to,discuss the possibility of filing a supplemental Biologics ...
... of Oxford Clinical Trial,Service Unit and Epidemiological Studies ... SEAS trial of ezetimibe should be,tested by reviewing ... trials of ezetimibe, and reporting on the overall ... drug,manufacturers., The two hypothesis-testing trials (SHARP and ...
Other Medicine Technology:CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 2CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 4Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe 2Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe 3
An aid for advancing a pacemaker lead through the subcutaneous tissue of the chest wall to the pacemaker pocket....
BonePlast is a fast resorbing, osteoconductive bone void filler. By delivering a high dose of calcium to the operative site, BonePlast helps build new bone during the healing process. Packaged in a c...
LifeStent FlexStar delivery systems offer clinicians multiple methods for stent deployment to accommodate individual preference....
... Osteon 200R is a resorbable, osteoconductive matrix ... cleared for use in oral maxillofacial procedures ... faster-resorbing Pro Osteon 200R has been FDA ... resorbs and is replaced with bone during ...
Medicine Products: